IL-13 binding agents

US7501121B2 · kind B2 · utility

Assignee

• Wyeth, LLC · US

Inventors

• Lioudmila Tchistiakova · Andover, US
• Marion T. Kasaian · Boston, US
• Debra Donaldson · Cambridge, US
• Xiang-Yang Tan · Reading, US
• Davinder Gill · Andover, US
• Macy Jin · Reading, US
• Bruce Jacobson · Framingham, US
• Samuel Goldman · Acton, US
• John Knopf · Carlisle, US
• Angela Widom · Acton, US

Key dates

• Filing date: Jun 17, 2005
• Grant date: Mar 10, 2009
• Expiry date: Mar 15, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13 and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediators are disclosed.